Year 5, N°17, September, 2002
Special Issue: World Congress of Nuclear Medicine

Poster Abstracts

Article Nº AJ17-17

1. CARDIOVASCULAR

A.N. Alvarado

1.01

OPTIMIZATION OF PERFUSION STUDIES USING ATROPINE

V.J. Arja

1.02

PROGNOSTIC VALUE OF MYOCARDIAL PERFUSION SPECT IMAGING IN ELDERLY PATIENTS WITHOUT HISTORY OF CORONARY ARTERY DISEASE AND LOW PREVALENCE OF THEM

V.R. Balestrini

1.03

INFLUENCE OF THE PREVALENCE OF CORONARY ARTERY DISEASE IN PATIENTS WITH NORMAL MYOCARDIAL PERFUSION SPECT IMAGING. COOPERATIVE STUDY IN SOUTH AMERICA

V.R. Balestrini

1.04

SEMIQUANTITATIVE SPECT MYOCARDIAL PERFUSION WITH DIPYRIDAMOLE IN PATIENTS UNABLES TO EXCERCISE. EVENT RATE DURING 4 YEARS OF FOLLOW UP

J. F. Batista

1.05

MONITORING GENE THERAPY BY NUCLEAR CARDIOLOGY PROCEDURES.A PORCINE MODEL OF CORONARY ARTERY DISEASE TREATED BY MEANS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (PVEGF)

J.U.M. Calegaro

1.06

FOLLOW-UP OF RHEUMATIC CARDITIS USING 67GA-CITRATE IMAGING

G.C. Campos-Neto

1.07

MYOCARDIAL PERFUSION: COMPARISON BETWEEN 99MTC-MIBI SCINTIGRAPHY AND MICROBUBBLES- PESDA AND LEVOVIST- ECHOCARDIOGRAPHY

I. Cho

1.08

ROLE OF MYOCARDIAL PERFUSION SPECT IN ASYMPTOMATIC DIABETIC PATIENTS

F.F. Faccio

1.09

FALSE POSITIVE DEFECTS ON EXERCISE MYOCARDIAL PERFUSION TOMOGRAPHY IN PATIENTS WITH A RIGHT VENTRICULAR PACEMAKER

A.M. Falcao

1.10

GATED-SPECT MYOCARDIAL SCINTIGRAPHY IN LEFT BUNDLE BRANCH BLOCK: A STUDY IN PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE.

A. Flotats

1.11

LV FUNCTION MONITORING TO DISCARD FUNCTIONAL ABNORMALITIES IN ATHLETES WITH ALTERED VENTRICULAR REPOLARIZATION

A. Flotats

1.12

MYOCARDIAL PERFUSION AFTER PROLONGED SUBMAXIMAL EXERCISE IN PATIENTS WITH CORONARY ARTERY DISEASE

F.M. González

1.13

VALUE OF THE FRACTION OF EJECTION AND THE END-DIASTOLIC VOLUME OF THE LEFT VENTRICLE CALCULATED BY MEANS OF GATED-SPECT

A.S. Hambye

1.14

QUANTIFICATION OF MYOCARDIAL PERFUSION SPECT FOR THE ASSESSMENT OF CORONARY ARTERY DISEASE: SHOULD WE APPLY SCATTER CORRECTION ?

A.S. Hambye

1.15

COMPARISON OF FOUR QUANTIFICATION METHODS FOR GATED SPECT EJECTION FRACTION: EFFECT OF MATRIX SIZE AND RECONSTRUCTION FILTER ON SMALL HEARTS

E. Havas

1.16

SIMULTANEOUS MEASUREMENT OF BLOOD FLOW AND LYMPH FLOW FROM HUMAN SKELETAL MUSCLE USING 133XE AND 99MTC-HSA. METHODOLOGICAL ASPECTS

J.M. Jimenez-Hoyuela

1.17

123I-MIBG MYOCARDIAL SYMPATHETIC INNERVATION SCINTIGRAPHY AND PARKINSON´S DISEASE

D. Ladrón de Guevara

1.18

REPRODUCIBILITY OF RADIONUCLIDE GATED CARDIAC BLOOD POOL IMAGING (GBPI) IN LEFT VENTRICULAR EJECTION FRACTION (LVEF) ASSESSMENT IN INFARCTED PATIENTS AND A HEALTHY YOUNG CONTROL POPULATION

J.T. Locher

1.19

DOUBLE CHAMBERED LEFT VENTRICEL: UNUSUAL PRESENTATION WITH AN APICAL DEFECT IN TL-201 SPET

K.B. Makhdomi

1.20

ROLE OF STRESS MYOCARDIAL PERFUSION SPECT SCAN IN DETECTION AND MANAGEMENT OF CORONARY ARTERY DISEASE: NAIROBI EXPERIENCE

S. Merlano

1.21

PROGNOSTIC VALUE OF SPECT-DYPIRIDAMOL AFTER ACUTE MYOCARDIAL INFARCTION

R.V. Parameswaran

1.22

COMPARISON OF NITRATE-AUGMENTED RESTING GATED 99MTC-SESTAMIBI IMAGING WITH LOW DOSE DOBUTAMINE SPECT FOR THE DETECTION OF MYOCARDIAL VIABILITY

V.P. Prassopoulos

1.23

ASSOCIATON OF MYOCARDIAL INOTROPIC RESERVE AND ADRENERGIC NERVE ALTERATIONS IN IDIOPATHIC DILATED CARDIOMYOPATHY. A DOBUTAMINE STRESS ECHOCARDIOGRAPHIC AND 123-I-MIBG SCINTIGRAPHIC STUDY.

V.P. Prassopoulos

1.24

THE EFFECT OF ALTERING THE ACTIVATION SEQUENCE WITH RIGHT VENTRICULAR APICAL PACING. EVALUATION OF MYOCARDIAL PERFUSION AND ADRENERGIC INNERVATION IN PATIENTS WITH RIGHT BUNDLE BRANCH BLOCK AND LEFT ANTERIOR FASCICULAR BLOCK.

M. Takano

1.25

CLINICAL MEANING OF MYOCARDIAL WASHOUT IN TC-MIBI AND TC-PPN (TETROFOSMIN) MYOCARDIAL SPECT IN NORMAL VOLUNTEERS

C. Vanhove

1.26

EFFECT OF MYOCARDIAL PERFUSION DEFECT EXTENT AND SEVERITY ON THE CALCULATION OF LV VOLUMES WITH GATED MYOCARDIAL PERFUSION TOMOGRAPHY. COMPARISON WITH GATED BLOOD POOL TOMOGRAPHY

C. Vanhove

1.27

MINIMAL COUNT LEVEL REQUIRED FOR QUANTIFICATION OF LEFT VENTRICULAR FUNCTION WITH GATED MYOCARDIAL PERFUSION TOMOGRAPHY

J.C. Wang

1.28

PRECLINICAL PHARMACOLOGICAL STUDY OF 99MTCN(NOET)2 AND COMPARISON WITH 201TL IN REDISTRIBUTION OF ISCHEMIA MYOCARDIUM

Nijensohn S MD

1.29

MYOCARDIAL PERFUSION GATED SPECT WITH 99mTc-SESTAMIBI: RESULTS IN 1128 PATIENTS FOLLOWED DURING 18 MONTHS IN ARGENTINA

Guzzo M MD

1.30

REST AND POSTSTRESS GATED SPECT: VENTRICULAR FUNCTION VALUES IN PROGNOSIS OF FUTURE CARDIAC EVENTS

Nijensohn S MD

1.31

REST AND STRESS GATED SPECT. NORMAL MYOCARDIAL PERFUSION:VENTRICULAR FUNCTION DATA IN THE FOLLOW UP

Cardiovascular |Cost Benefits|Endocrinology |Gastroenterology |Hematology |Infection| Musculoskeletal |Nephro-Urology |Neuro-Psychiatric Disorders |Oncology Diagnosis |Oncology Therapy |Pediatrics|Physics |Pulmonary |Radiopharmacy |Technology

 

 

Sitio desarrollado por SISIB - Universidad de Chile